Adaptive Biotechnologies
ADPT
ADPT
226 hedge funds and large institutions have $931M invested in Adaptive Biotechnologies in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 82 increasing their positions, 59 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
226
Holders Change
+17
Holders Change %
+8.13%
% of All Funds
3.91%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
82
Reduced
59
Closed
25
Calls
$1.23M
Puts
$522K
Net Calls
+$704K
Net Calls Change
-$502K
Top Buyers
| 1 |
BlackRock
New York
|
$72.1M |
| 2 |
Goldman Sachs
New York
|
$13.6M |
| 3 |
AAP
Aristotle Atlantic Partners
Sarasota,
Florida
|
$13.5M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
$66.5M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
$3.56M |
